newsfilter
← Latest News
Business Wire·

AlloVir to Participate in the Piper Sandler 34th Annual Healthcare Conference

AlloVir, Inc. (NASDAQ:ALVR), a late-clinical stage allogeneic T-cell immunotherapy company, today announced that Diana Brainard, M.D., Chief Executive Officer, will participate in a fireside chat at the Piper Sandler